Johnson & Johnson Pauses Coronavirus Vaccine Trial Over Unexplained Illness
Johnson & Johnson has paused its COVID-19 vaccine trial after an “unexplained illness” of one the participants. The vaccine is currently in development as part of a partnership between Johnson & Johnson and a team led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC).